NEW YORK (GenomeWeb) – DNA Electronics said today that the Biomedical Advanced Research and Development Authority has approved the second phase of a contract for the development of a next-generation sequencing platform for rapid diagnosis of antimicrobial resistant infections and influenza.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.